(Q34552167)

3 August 2017

1 reference

title

Ontogeny and expansion of human natural killer cells: clinical implications (English)

1 reference

3 August 2017

Fehniger TA

1

1 reference

3 August 2017

Caligiuri MA

series ordinal

2

1 reference

3 August 2017

language of work or name

1 reference

1 June 2001

1 reference

International Reviews of Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

20

1 reference

3 August 2017

issue

3-4

1 reference

3 August 2017

page(s)

503-534

1 reference

Biology of natural killer cells

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Natural killer cells: from no receptors to too many

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Development and tolerance of natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Regulation of immune responses through inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Arousal and inhibition of human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The IL-2 receptor complex: its structure, function, and target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Interleukin-2, interleukin-15, and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Expression of a functional c-kit receptor on a subset of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

CD3-Leukocytes Present in the Human Uterus During Early Placentation: Phenotypic and Morphologic Characterization of the CD56++Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Activation of natural killer cells via the p75 interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Mechanisms of genetic resistance to friend virus leukemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Production and differentiation of NK lineage cells in long-term bone marrow cultures in the absence of exogenous growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

A potential role for interleukin-15 in the regulation of human natural killer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Recombinant interleukin 2 therapy in severe combined immunodeficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Immunological Unresponsiveness in Leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Impaired interleukin 12 production in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Defective natural immunity: an early manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

The immunopathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Costimulation of human natural killer cells is required for interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Immune responses in interleukin-2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

IL-15 Mediates Anti-tumor Effects after Cyclophosphamide Injection of Tumor-Bearing Mice and Enhances Adoptive Immunotherapy: The Potential Role of NK Cell Subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180109054417

10.3109/08830180109054417

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference